Scipher Medicine CEO and Rheumatologists React to PrismTcell Launch
Scipher Medicine has revealed its intention to roll out an early physician access initiative for PrismTcell, a molecular treatment response signature test utilizing a blood sample to forecast how rheumatoid ... Read More